Mark Mellinger

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations

Ezh2 Inhibition, Lymphoid Neoplasia, Hematological Malignancy +10

An Investigation of Imidazole and Oxazole Syntheses Using Aryl-Substituted TosMIC Reagents¹

Joseph Sisko, Andrew J. Kassick, Mark Mellinger et al. · The Journal of Organic Chemistry · 2000 · 157 citations

Single Pot, Mild Protocols, Engineering +9

An efficient method for the synthesis of substituted TosMIC precursors

Joseph Sisko, Mark Mellinger, Peter Sheldrake et al. · Tetrahedron Letters · 1996 · 54 citations

Combinatorial Chemistry, Engineering, Organic Chemistry +7

Development of a general process for the synthesis of highly substituted imidazoles

Joseph Sisko, Mark Mellinger · Pure and Applied Chemistry · 2002 · 32 citations · Full text

Medicinal Chemistry, Aryl-substituted Tosmic Reagents, Drug Discovery +14

Novel syntheses of camptothecin alkaloids, part 2. concise synthesis of (S)-camptothecins

Joseph Fortunak, John Kitteringham, A. R. MASTROCOLA et al. · Tetrahedron Letters · 1996 · 31 citations

Part 2., Biochemistry, Novel Syntheses +7